Список литературы

1. Мень Т.Х., Поляков В.Г., Алиев М.Д. Эпидемиология злокачественных новообразований у детей в России.//Онкопедиатрия. 2014. Vol. 1. P. 7 - 12.

2. Дурнов Л.А., Голдобенко Г.В. Учебник "Детская онкология". 2002. 607 p.

3. Поляков В.Г. Опухоли головы и шеи у детей//Опухоли головы и шеи. Пятое издание, переработанное. Под ред. А.И. Пачеса. 2013. P. 454 - 473.

4. Детская онкология. Национальное руководство. Под ред. М.Д. Алиева, В.Г. Полякова, Г.Л. Менткевича, С.А. Маяковой. М.: Издательская группа РОНЦ. Практическая медицина, 2012. 684 p.

5. Румянцев П.О. et al. Рак щитовидной железы. Современные подходы к диагностике и лечению. М.: Издательская группа ГЭОТАР-Медиа, 2009. 447 p.

6. Lapunzina P., Cohen M.M. Risk of tumorigenesis in overgrowth syndromes: A comprehensive review//American Journal of Medical Genetics - Seminars in Medical Genetics. 2005. Vol. 137 C, N 1. P. 53 - 71.

7. Masciari S. et al. F18-fluorodeoxyglucose - Positron emission tomography/computed tomography screening in Li-Fraumeni syndrome//JAMA - J. Am. Med. Assoc. 2008. Vol. 299, N 11. P. 1315 - 1319.

8. Collins M.T. et al. Thyroid carcinoma in the McCune-Albright syndrome: Contributory role of activating mutations//J. Clin. Endocrinol. Metab. 2003. Vol. 88, N 9. P. 4413 - 4417.

9. Triggiani V. et al. Papillary thyroid carcinoma in peutz-jeghers syndrome//Thyroid. 2011. Vol. 21, N 11. P. 1273 - 1277.

10. Niedziela M. Pathogenesis, diagnosis and management of thyroid nodules in children//Endocrine-Related Cancer. 2006. Vol. 13, N 2. P. 427 - 453.

11. Leenhardt L., Aurengo A. Post-Chernobyl thyroid carcinoma in children//Best Pract. Res. Clin. Endocrinol. Metab. Bailliere Tindall Ltd, 2000. Vol. 14, N 4. P. 667 - 677.

12. Sklar C. et al. Abnormalities of the Thyroid in Survivors of Hodgkin's Disease: Data from the Childhood Cancer Survivor Study 1//J. Clin. Endocrinol. Metab. The Endocrine Society, 2000. Vol. 85, N 9. P. 3227 - 3232.

13. Jacob P. et al. Thyroid Cancer Risk in Areas of Ukraine and Belarus Affected by the Chernobyl Accident//Radiat. Res. Radiation Research Society, 2006. Vol. 165, N 1. P. 1 - 8.

14. Meadows A.T. et al. Second neoplasms in survivors of childhood cancer: Findings from the Childhood Cancer Survivor Study cohort//Journal of Clinical Oncology. 2009. Vol. 27, N 14. P. 2356 - 2362.

15. Ronckers C.M. et al. Thyroid cancer in childhood cancer survivors: a detailed evaluation of radiation dose response and its modifiers.//Radiat. Res. 2006. Vol. 166, N 4. P. 618 - 628.

16. Поляков В.Г. et al. Результаты профилактической тиреоидэктомии у носителей герминальной мутации в гене RET в семьях с наследственными формами медуллярного рака щитовидной железы//Клиническая и экспериментальная тиреоидология. 2016. Vol. 12, N 1. P. 22 - 33.

17. Eckelt F. et al. Calcitonin measurement in pediatrics: Reference ranges are gender-dependent, validation in medullary thyroid cancer and effects of thyroid diseases//Clin. Chem. Lab. Med. De Gruyter, 2019. Vol. 57, N 8.

18. Газизова Д.О., Бельцевич Д.Г. Современный взгляд на проблему диагностики и лечения медуллярного рака щитовидной железы//Эндокринная хирургия. 2013. Vol. 7, N 3. P. 4 - 21.

19. Shimamoto K. et al. Preoperative staging of thyroid papillary carcinoma with ultrasonography.//Eur. J. Radiol. 1998. Vol. 29, N 1. P. 4 - 10.

20. Alzahrani A.S. et al. Lung metastasis in pediatric thyroid cancer: Radiological pattern, molecular genetics, response to therapy, and outcome//J. Clin. Endocrinol. Metab. Oxford University Press, 2019. Vol. 104, N 1. P. 103 - 110.

21. Miyakoshi A., Dalley R.W., Anzai Y. Magnetic resonance imaging of thyroid cancer//Topics in Magnetic Resonance Imaging. 2007. Vol. 18, N 4. P. 293 - 302.

22. Francis G.L. et al. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer//Thyroid. Mary Ann Liebert Inc., 2015. Vol. 25, N 7. P. 716 - 759.

23. Vainas I. et al. The Therapeutic Value of SST-A Octreotide Alone or With Adjuvant Treatment in Patients With Advanced Medullary Thyroid Carcinoma and Positive (111)In-octreotide Scan//Hell. J. Nucl. Med. 2005. Vol. 8, N 1. P. 43 - 47.

24. Buraggi G.L. et al. Clinical Examination and 131 Cs Scanning in the Diagnosis of Cold Nodules of the Thyroid//Tumori. 1976. Vol. 62, N 4. P. 379 - 405.

25. Nervo A. et al. Bone metastases from differentiated thyroid carcinoma: current knowledge and open issues//Journal of Endocrinological Investigation. Springer, 2020. P. 1 - 17.

26. Verburg F.A., van Santen H., Luster M. Pediatric papillary thyroid cancer: current management challenges//Onco. Targets. Ther. Dove Medical Press Ltd., 2016. Vol. Volume 10. P. 165 - 175.

27. Dong M.-J. et al. Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: A meta-analysis//Nucl. Med. Commun. 2009. Vol. 30, N 8. P. 639 - 650.

28. Miller M.E. et al. Positron emission tomography and positron emission tomography-CT evaluation for recurrent papillary thyroid carcinoma: Meta-analysis and literature review//Head Neck. 2011. Vol. 33, N 4. P. 562 - 565.

29. Esteva D. et al. Clinical and pathological factors related to 18F-FDG-PET positivity in the diagnosis of recurrence and/or metastasis in patients with differentiated thyroid cancer//Ann. Surg. Oncol. Springer, 2009. Vol. 16, N 7. P. 2006 - 2013.

30. Treglia G. et al. The role of positron emission tomography and positron emission tomography/computed tomography in thyroid tumours: An overview//European Archives of Oto-Rhino-Laryngology. 2013. Vol. 270, N 6. P. 1783 - 1787.

31. O'Riordain D.S. et al. Multiple endocrine neoplasia type 2B: More than an endocrine disorder//Surgery. Surgery, 1995. Vol. 118, N 6. P. 936 - 942.

32. Barbosa T.L.M. et al. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology//BMC Endocr. Disord. BioMed Central Ltd., 2019. Vol. 19, N 1. P. 112.

33. Stevens C. et al. Pediatric thyroid fine-needle aspiration cytology: a meta-analysis//Journal of Pediatric Surgery. J Pediatr Surg, 2009. Vol. 44, N 11. P. 2184 - 2191.

34. Yang J. et al. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations.//Cancer. 2007. Vol. 111, N 5. P. 306 - 315.

35. Cibas E.S., Ali S.Z. The bethesda system for reporting thyroid cytopathology//Thyroid. 2009. Vol. 19, N 11. P. 1159 - 1165.

36. Baloch Z.W. et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: A synopsis of the national cancer institute thyroid fine-needle aspiration state of the science conference//Diagnostic Cytopathology. 2008. Vol. 36, N 6. P. 425 - 437.

37. Smith M. et al. Indeterminate pediatric thyroid fine needle aspirations: A study of 68 cases//Acta Cytol. S. Karger AG, 2013. Vol. 57, N 4. P. 341 - 348.

38. Monaco S.E. et al. Cytomorphological and molecular genetic findings in pediatric thyroid fine-needle aspiration//Cancer Cytopathol. 2012. Vol. 120, N 5. P. 342 - 350.

39. Udelsman R. Thyroid cancer surgery.//Rev. Endocr. Metab. Disord. 2000. Vol. 1, N 3. P. 155 - 163.

40. Jouini R. et al. The Value of Intra-Operative Frozen Section in Thyroid Neoplasm Management: Experience of One Center. 2017.

41. Sinha C.K. et al. Thyroid Surgery in Children: Clinical Outcomes//Eur. J. Pediatr. Surg. Georg Thieme Verlag, 2014. Vol. 25, N 5. P. 425 - 429.

42. Spinelli C. et al. Surgical management of follicular thyroid carcinoma in children and adolescents: A study of 30 cases//J. Pediatr. Surg. W.B. Saunders, 2019. Vol. 54, N 3. P. 521 - 526.

43. Carty S.E. et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer//Thyroid. 2009. Vol. 19, N 11. P. 1153 - 1158.

44. Stack B.C. et al. American thyroid association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer//Thyroid. 2012. Vol. 22, N 5. P. 501 - 508.

45. Vaisman F. et al. Prognostic factors of a good response to initial therapy in children and adolescents with differentiated thyroid cancer//Clinics. 2011. Vol. 66, N 2. P. 281 - 286.

46. B. et al. Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children//Eur. J. Nucl. Med. 2000. Vol. 27, N 7. P. 833 - 841.

47. Hay I.D. et al. Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008//World J. Surg. 2010. Vol. 34, N 6. P. 1192 - 1202.

48. Bargren A.E. et al. Outcomes of Surgically Managed Pediatric Thyroid Cancer//J. Surg. Res. 2009. Vol. 156, N 1. P. 70 - 73.

49. Demidchik Y.E. et al. Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus//Ann. Surg. Lippincott Williams and Wilkins, 2006. Vol. 243, N 4. P. 525 - 532.

50. Liu X. et al. Evolutionary features of thyroid cancer in patients with thyroidectomies from 2008 to 2013 in China//Sci. Rep. Nature Publishing Group, 2016. Vol. 6.

51. Niederle B., Sebag F., Brauckhoff M. Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease - A consensus statement of the European Society of Endocrine Surgeons (ESES)//Langenbeck's Archives of Surgery. Springer Verlag, 2014. Vol. 399, N 2. P. 185 - 197.

52. Frasoldati A. et al. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma//Cancer. 2003. Vol. 97, N 1. P. 90 - 96.

53. Cooper D.S. et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer//Thyroid. Mary Ann Liebert Inc, 2006. Vol. 16, N 2. P. 109 - 141.

54. Hahn K. et al. Thyroid cancer after diagnostic administration of iodine-131 in childhood.//Radiat. Res. 2001. Vol. 156, N 1. P. 61 - 70.

55. Hung W., Sarlis N.J. Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: A review//Thyroid. 2002. Vol. 12, N 8. P. 683 - 702.

56. Leboulleux S. et al. Follicular-cell derived thyroid cancer in children//Eur. J. Cancer. Elsevier Ltd, 2004. Vol. 40, N 11. P. 1655 - 1659.

57. Radakrishnan A. et al. Hypocalcemia prevention and management after thyroidectomy in children: a systematic review//J. Pediatr. Surg. Elsevier BV, 2020. Vol. 0, N 0.

58. Waguespack S.G. et al. The successful use of sorafenib to treat pediatric papillary thyroid carcinoma//Thyroid. Thyroid, 2009. Vol. 19, N 4. P. 407 - 412.

59. Iyer P., Mayer J.L.R., Ewig J.M. Response to sorafenib in a pediatric patient with papillary thyroid carcinoma with diffuse nodular pulmonary disease requiring mechanical ventilation//Thyroid. Thyroid, 2014. Vol. 24, N 1. P. 169 - 174.

60. Kraft I.L. et al. Outcomes of children and adolescents with advanced hereditary medullary thyroid carcinoma treated with vandetanib//Clin. Cancer Res. American Association for Cancer Research Inc., 2018. Vol. 24, N 4. P. 753 - 765.

61. Spinelli C. et al. Surgical management of medullary thyroid carcinoma in pediatric age//Population Research and Policy Review. Springer Netherlands, 2016. Vol. 12, N 4. P. 280 - 285.

62. Диагностика и лечение медуллярного рака щитовидной железы. Национальные клинические рекомендации.//Опухоли головы и шеи. 2013. Vol. 4. P. 36 - 45.

63. Kloos R.T. et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association.//Thyroid: official journal of the American Thyroid Association. Thyroid, 2009. Vol. 19, N 6. P. 565 - 612.

64. Park J.-I., Starenki D. Pediatric Medullary Thyroid Carcinoma//J. Pediatr. Oncol. Pharma Publisher, 2016. Vol. 3, N 2. P. 29 - 37.

65. Rivkees S.A. et al. The treatment of differentiated thyroid cancer in children: Emphasis on surgical approach and radioactive iodine therapy//Endocrine Reviews. The Endocrine Society, 2011. Vol. 32, N 6. P. 798 - 826.

66. Brandi M.L. et al. Consensus: Guidelines for diagnosis and therapy of MEN type 1 and type 2//Journal of Clinical Endocrinology and Metabolism. Endocrine Society, 2001. Vol. 86, N 12. P. 5658 - 5671.

67. Perros P. et al. Guidelines for the management of thyroid cancer//Clin. Endocrinol. (Oxf). Blackwell Publishing Ltd, 2014. Vol. 81, N SUPPL. 1. P. 1 - 122.

68. Elisei R. et al. 2012 European Thyroid Association Guidelines for Genetic Testing and Its Clinical Consequences in Medullary Thyroid Cancer//Eur. Thyroid J. S. Karger AG, 2013. Vol. 1, N 4. P. 216 - 231.

69. Wells S.A. et al. Revised American thyroid association guidelines for the management of medullary thyroid carcinoma//Thyroid. Mary Ann Liebert Inc., 2015. Vol. 25, N 6. P. 567 - 610.

70. Mhiri A. et al. Differentiated Thyroid Cancer in Children: The Contribution of Radioiodine Therapy. 2015.

71. Lin J. Der et al. The efficacy of radioactive iodine for the treatment of well-differentiated thyroid cancer with distant metastasis//Nucl. Med. Commun. Lippincott Williams and Wilkins, 2018. Vol. 39, N 12. P. 1091 - 1096.

72. Waguespack S.G., Francis G.L. Current understanding and treatment of differentiated thyroid cancer in children-a review//US Endocrinology. 2010. Vol. 6, N 1. P. 84 - 91.

73. Tanner L. et al. Cancer Rehabilitation in the Pediatric and Adolescent/Young Adult Population//Seminars in Oncology Nursing. Elsevier Inc, 2020. Vol. 36, N 1. P. 150984.

74. Kim H.Y., Gelfand M.J., Sharp S.E. SPECT/CT imaging in children with papillary thyroid carcinoma//Pediatr. Radiol. 2011. Vol. 41, N 8. P. 1008 - 1012.

75. Zanella A.B. et al. Dynamic Risk Stratification in the Follow-Up of Children and Adolescents with Differentiated Thyroid Cancer//Thyroid. Mary Ann Liebert Inc., 2018. Vol. 28, N 10. P. 1285 - 1292.

76. Wassner A.J. et al. Prevalence and significance of thyroglobulin antibodies in pediatric thyroid cancer//J. Clin. Endocrinol. Metab. Oxford University Press, 2017. Vol. 102, N 9. P. 3146 - 3153.

77. Wu S.Y. et al. Risks of Hypoparathyroidism After Total Thyroidectomy in Children: A 21-Year Experience in a High-Volume Cancer Center//World J. Surg. Springer, 2020. Vol. 44, N 2. P. 442 - 451.